NHS Medicines Industry Partnership Programme (MIPP)

NHS ML has developed a service to deliver medicines optimisation for patients to support Integrated Care QIPP plans funded by private-public partnership.

The MIPP is aligned to the aims of the ICB and NICE guidance, and brings in clinical staff funded via private sector to support GP practices with medication review in line with the local QIPP plans. NHS ML provides the programme management, quality assurance, governance and oversight of the service to ensure that the service aligns to NHS aims and delivers patient centred care with a legacy for the NHS & GP practices. This service has been developed and is led by the clinical medicines optimisation team in NHS ML and is part of the CSUs Lifesciences offer.